Guglielmini, P., A. Serao, S. Zai, P.L. Piovano, and F. Grosso. “Second-Line Treatment With Axitinib: An Effective and Well-Tolerated Weapon in the Therapeutic Sequence of Clear Cell Renal Cell Carcinoma”. Working Paper of Public Health 4, no. 1 (June 15, 2015). Accessed May 17, 2024. https://www.pagepress.org/journals/wpph/article/view/6697.